PortfoliosLab logoPortfoliosLab logo
Personalis, Inc. (PSNL)
Performance
Return for Risk
Dividends
Drawdowns
Volatility
Financials

Company Info

ISIN
US71535D1063
CUSIP
71535D106
IPO Date
Jun 20, 2019

Highlights

Market Cap
$587.83M
Enterprise Value
$495.45M
EPS (TTM)
-$0.90
Total Revenue (TTM)
$52.30M
Gross Profit (TTM)
-$1.57M
EBITDA (TTM)
-$75.05M
Year Range
$2.83 - $11.50
Target Price
$11.25
ROA (TTM)
-24.32%
ROE (TTM)
-31.12%

Share Price Chart


Loading graphics...

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Personalis, Inc.

Performance

Performance Chart

The chart shows the growth of an initial investment of $10,000 in Personalis, Inc., comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.


Loading graphics...

S&P 500 Index

Returns By Period

Personalis, Inc. (PSNL) has returned -19.97% so far this year and 81.48% over the past 12 months.


Personalis, Inc.

1D
2.08%
1M
-29.69%
YTD
-19.97%
6M
-2.30%
1Y
81.48%
3Y*
32.15%
5Y*
-23.38%
10Y*

Benchmark (S&P 500 Index)

1D
2.91%
1M
-5.09%
YTD
-4.63%
6M
-2.39%
1Y
16.33%
3Y*
16.69%
5Y*
10.18%
10Y*
12.16%
*Multi-year figures are annualized to reflect compound growth (CAGR)

Monthly Returns

Based on dividend-adjusted daily data since Jun 20, 2019, PSNL's average daily return is +0.10%, while the average monthly return is +1.65%. At this rate, your investment would double in approximately 3.5 years.

Historically, 43% of months were positive and 57% were negative. The best month was Jul 2024 with a return of +194.9%, while the worst month was Jan 2024 at -36.2%. The longest winning streak lasted 5 consecutive months, and the longest losing streak was 6 months.

On a daily basis, PSNL closed higher 47% of trading days. The best single day was Jul 19, 2024 with a return of +57.1%, while the worst single day was Jul 22, 2024 at -22.6%.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
202617.71%-3.31%-29.69%-19.97%
2025-9.69%-20.69%-15.22%7.69%22.49%41.68%-16.46%-10.77%33.33%47.85%11.31%-25.82%37.72%
2024-36.19%15.67%-3.87%-1.34%-11.56%-10.00%194.87%57.68%-1.10%-6.13%-21.39%45.59%175.24%
202318.69%28.09%-8.31%-17.39%-21.05%4.44%25.53%-22.88%-33.52%-20.48%59.01%37.25%6.06%
2022-20.18%-7.81%-22.00%-31.62%-29.29%-12.88%6.96%-10.30%-10.27%-10.10%-4.87%-22.05%-86.12%
20215.08%-19.86%-20.18%0.12%-8.73%12.49%-17.04%0.91%-9.16%1.98%-30.94%5.31%-61.02%

Benchmark Metrics

Personalis, Inc. has an annualized alpha of 1.09%, beta of 1.68, and R² of 0.12 versus S&P 500 Index. Calculated based on daily prices since June 21, 2019.

  • This stock participated in 192.67% of S&P 500 Index downside but only 86.45% of its upside — more exposed to losses than it benefited from rallies.
  • R² of 0.12 means this stock moves largely independently of S&P 500 Index — capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.

Alpha
1.09%
Beta
1.68
0.12
Upside Capture
86.45%
Downside Capture
192.67%

Return for Risk

Risk / Return Rank

PSNL ranks 71 for risk / return — better than 71% of stocks on our site. You're getting solid returns for the risk taken. A good sign, especially for investors who want growth without excessive volatility.


PSNL Risk / Return Rank: 7171
Overall Rank
PSNL Sharpe Ratio Rank: 7070
Sharpe Ratio Rank
PSNL Sortino Ratio Rank: 7272
Sortino Ratio Rank
PSNL Omega Ratio Rank: 7070
Omega Ratio Rank
PSNL Calmar Ratio Rank: 7373
Calmar Ratio Rank
PSNL Martin Ratio Rank: 7070
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

Return / Risk — by metrics

The table below present risk-adjusted performance metrics for Personalis, Inc. (PSNL) and compare them to a chosen benchmark (S&P 500 Index).


PSNLBenchmarkDifference

Sharpe ratio

Return per unit of total volatility

0.89

0.90

-0.01

Sortino ratio

Return per unit of downside risk

1.73

1.39

+0.35

Omega ratio

Gain probability vs. loss probability

1.22

1.21

+0.01

Calmar ratio

Return relative to maximum drawdown

1.71

1.40

+0.31

Martin ratio

Return relative to average drawdown

3.63

6.61

-2.98

Explore PSNL risk-adjusted metrics in detail

Dive deeper into individual metrics with historical trends, benchmark comparisons, and performance across different time periods.

Dividends

Dividend History


Personalis, Inc. doesn't pay dividends

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.


Loading graphics...

Worst Drawdowns

The table below displays the maximum drawdowns of the Personalis, Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Personalis, Inc. was 98.18%, occurring on Oct 23, 2023. The portfolio has not yet recovered.

The current Personalis, Inc. drawdown is 87.51%.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-98.18%Jan 21, 2021694Oct 23, 2023
-84.3%Jun 24, 2019184Mar 16, 2020145Oct 9, 2020329
-25.91%Dec 23, 20209Jan 6, 20218Jan 19, 202117
-19.5%Oct 12, 202016Nov 2, 202014Nov 20, 202030
-18.45%Nov 23, 20202Nov 24, 20208Dec 7, 202010

Volatility

Volatility Chart

The chart below shows the rolling one-month volatility.


Loading graphics...

Financials

Financial Performance

The chart below illustrates the trends in the financial health of Personalis, Inc. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.


Annual
Quarterly

0.0

Valuation

The Valuation section provides an overview of how Personalis, Inc. is priced in the market compared to other companies in the Diagnostics & Research industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.


PS Ratio

This chart shows the Price-to-Sales (P/S) ratio for PSNL relative to other companies in the Diagnostics & Research industry. Currently, PSNL has a P/S ratio of 10.9. This P/S ratio is high relative to other companies in the industry. It could mean the stock is overvalued, or that investors expect strong future growth and profitability.

PB Ratio

The chart illustrates the Price-to-Book (P/B) ratio for PSNL in comparison with other companies in the Diagnostics & Research industry. Currently, PSNL has a P/B value of 2.3. This P/B ratio is in line with the industry average, suggesting the stock is valued fairly in relation to its book value.

Income Statement



TTM
Revenue

Total Revenue

Cost Of Revenue

Gross Profit

Operating Expenses

Selling, General & Admin Expenses

R&D Expenses

Depreciation And Amortization

Total Operating Expenses

Income

Income Before Tax

Operating Income

EBITDA

EBIT

Earnings From Continuing Operations

Net Income

Income Tax Expense

Other Non-Operating Income (Expenses)

Extraordinary Items

Discontinued Operations

Effect Of Accounting Charges

Non Recurring

Minority Interest

Other Items

Interest Income

Interest Expense

Net Interest Income

Values in undefined except per share items